中文

诺思格 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-28

诺思格 reported revenue of ¥0.47B for the period ended 2026-06-30, +23.3% year on year. Net income was ¥0.05B, a 9.7% net margin on a 30.2% gross margin. The largest revenue line is 临床试验相关及实验室服务 at 51% of the total. Free cash flow for the period was ¥-0.00B.

ItemAmountY/Y
Revenue¥0.47B+23.3%
Gross profit¥0.14B
Operating income¥0.05B
Net income¥0.05B-26.3%
Gross margin30.2%Net margin 9.7%
Revenue Q/Q+14.6%

Revenue Segments

SegmentRevenueShare
临床试验相关及实验室服务¥0.24B50.8%
临床试验技术服务¥0.23B49.2%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.33B69.8%
R&D¥0.03B7.2%
SG&A¥0.05B10.2%
Tax & other¥0.01B1.6%

Balance sheet & cash flow

ItemAmount
Total assets¥2.40B
Total liabilities¥0.40B
Shareholders' equity¥2.01B
Equity / assets83.5%
Operating cash flow¥0.00B
Capital expenditure¥0.00B
Free cash flow¥-0.00B
Cash conversion (OCF / net income)-33%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

天元宠物趣睡科技亚华电子凯格精机通行宝涛涛车业蓝箭电子信德新材普莱得南王科技天振股份北方长龙

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies